IBDEI0ZG ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15814,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,15814,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,15815,0)
 ;;=M34.2^^88^869^313
 ;;^UTILITY(U,$J,358.3,15815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15815,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,15815,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,15815,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,15816,0)
 ;;=M34.81^^88^869^315
 ;;^UTILITY(U,$J,358.3,15816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15816,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,15816,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,15816,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,15817,0)
 ;;=M34.82^^88^869^316
 ;;^UTILITY(U,$J,358.3,15817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15817,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,15817,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,15817,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,15818,0)
 ;;=M34.83^^88^869^317
 ;;^UTILITY(U,$J,358.3,15818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15818,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,15818,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,15818,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,15819,0)
 ;;=M34.89^^88^869^314
 ;;^UTILITY(U,$J,358.3,15819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15819,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,15819,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,15819,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,15820,0)
 ;;=M34.9^^88^869^318
 ;;^UTILITY(U,$J,358.3,15820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15820,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,15820,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,15820,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,15821,0)
 ;;=R21.^^88^869^297
 ;;^UTILITY(U,$J,358.3,15821,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15821,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,15821,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,15821,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,15822,0)
 ;;=R23.3^^88^869^309
 ;;^UTILITY(U,$J,358.3,15822,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15822,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,15822,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,15822,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,15823,0)
 ;;=L03.113^^88^869^114
 ;;^UTILITY(U,$J,358.3,15823,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15823,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,15823,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,15823,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,15824,0)
 ;;=L03.114^^88^869^107
 ;;^UTILITY(U,$J,358.3,15824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15824,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,15824,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,15824,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,15825,0)
 ;;=L03.115^^88^869^111
 ;;^UTILITY(U,$J,358.3,15825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15825,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,15825,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,15825,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,15826,0)
 ;;=L03.116^^88^869^104
 ;;^UTILITY(U,$J,358.3,15826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15826,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,15826,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,15826,2)
 ;;=^5133645
